Guangdong Transtek Medical Electronics Co., Ltd

Shenzhen Stock Exchange 300562.SZ

Guangdong Transtek Medical Electronics Co., Ltd EBITDA for the year ending December 31, 2023: USD 10.48 M

Guangdong Transtek Medical Electronics Co., Ltd EBITDA is USD 10.48 M for the year ending December 31, 2023, a 1,488.13% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Guangdong Transtek Medical Electronics Co., Ltd EBITDA for the year ending December 31, 2022 was USD -754.65 K, a -120.36% change year over year.
  • Guangdong Transtek Medical Electronics Co., Ltd EBITDA for the year ending December 31, 2021 was USD 3.71 M, a -73.23% change year over year.
  • Guangdong Transtek Medical Electronics Co., Ltd EBITDA for the year ending December 31, 2020 was USD 13.85 M, a 70.25% change year over year.
  • Guangdong Transtek Medical Electronics Co., Ltd EBITDA for the year ending December 31, 2019 was USD 8.13 M, a 9.64% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
SV Wall Street
Shenzhen Stock Exchange: 300562.SZ

Guangdong Transtek Medical Electronics Co., Ltd

CEO Mr. Wei Chao Pan
IPO Date Nov. 16, 2016
Location China
Headquarters Zone A
Employees 1,286
Sector Healthcare
Industries
Telehealth 3D Printing Eyewear Hardware & Electronics Medical Instruments Pharmaceuticals Robotics
Description

Guangdong Transtek Medical Electronics Co., Ltd designs, manufactures, and sells medically approved products, connected healthcare devices, and smart wearables in China. The company offers remote patient monitoring devices, blood pressure monitors, electronic scales, multifunctional wearable, and wireless hearable devices. Guangdong Transtek Medical Electronics Co., Ltd was founded in 2002 and is based in Zhongshan, China.

StockViz Staff

February 4, 2025

Any question? Send us an email